Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Shenzhen MingSight Relin Pharmaceuticals

2 clinical trials

Clinical trial
A Multicenter, Open-label, Dose Escalation Study Assessing the Safety and Treatment Effects of MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Status: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
A Phase I/II Study to Investigate the Efficacy and Safety of MS-553 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Recruiting, Estimated PCD: 2024-04-01